Back to Companies
Hepion Pharmaceuticals, Inc.
HEPAOTCCIK: 0001583771
Over the 8 most recent insider filings, Hepion Pharmaceuticals, Inc. (HEPA) has seen activity from 7 distinct insiders — all of them on the buy side. The activity is heavily weighted toward buying: $400.0K bought versus $0 sold, a net purchase of $400.0K. LoPriore Vincent S (Executive Chairman, Director, 10% Owner) is the most active by dollar volume, and the single largest transaction was $250.0K by LoPriore Vincent S. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$400.0K
Purchases
$400.0K
Sales
$0
Unique Insiders
7
Recent Insider Trades
8 loaded
| Jul 10 | HEPA Hepion Pharmaceuticals, Inc. | Stetz Gary S. II | Director | Other | $0 |
| Jul 8 | HEPA Hepion Pharmaceuticals, Inc. | Fisher Danina | Director | Other | $0 |
| Apr 27 | HEPA Hepion Pharmaceuticals, Inc. | Appajosyula Sireesh | Director | Buy | $50.0K |
| Apr 27 | HEPA Hepion Pharmaceuticals, Inc. | Stetz Gary S. | Interim CEO, Director | Buy | $50.0K |
| Apr 27 | HEPA Hepion Pharmaceuticals, Inc. | LoPriore Vincent S | Executive Chairman, Director, 10% Owner | Buy | $250.0K |
| Apr 27 | HEPA Hepion Pharmaceuticals, Inc. | Purcell Michael J. | Director | Buy | $50.0K |
| Mar 18 | HEPA Hepion Pharmaceuticals, Inc. | Appajosyula Sireesh | Director | Other | $0 |
| May 26 | HEPA Hepion Pharmaceuticals, Inc. | LoPriore Chase | Director | Other | $0 |
8 filings